1. atherosclerosis condition in which fatty deposits called plaque build up on the inner walls of the
arteries
- dx by serum lipid profile
2. normal choles- <200 mg/dL
terol level
3. normal triglyc- around 40
eride level
4. normal HDL 40+ mg/dL
(good lipid) level
5. normal LDL level <100 mg/dL
6. arteriosclerosis hardening of the arteries
- happens in conjunction with atherosclerosis
s/s: intermittent claudication, dizziness, paleness
tx: lifestyle changes, meds (vasodilators)
7. antilipemic meds 'statins
- reduces cholesterol within 2 weeks of starting
top se: muscle weakness/pain bc it can l/t rhabdo
- need liver tests every 6mos
8. CAD obstruction of 75% of one or more coronary arteries
s/s: similar to angina: SOB, tachy, ischemia (lack of blood flow to area)
9. CAD treatment: quit smoking, diet, exercise, control of angina, hypertension, anticoagulant therapy
10. what is major risk smoking
factor for heart
disease
, 11. angina insuflcient coronary blood flow- cardiac muscles deprived of oxygen
- most common cause: narrow lumen
12. stable angina chest pain that occurs when a person is active or under severe stress, relieved with
rest or nitro
13. unstable angina chest pain that occurs while a person is at rest and not exerting himself
- s/s: pressure or squeezing sensation in left arm, feeling a sense of doom
- not received with rest or nitro
14. medical manage- o2, telly monitoring, frequent VS, have cardiac labs drawn
ment of angina
15. meds for long vasodilators, beta blockers, calcium channel blockers
term angina pre-
vention
16. side effects of ni- headache, dizziness, hypotension, flushing, faintness. take Tylenol for headache
trates
17. how is nitro taken can be taken every 5 minutes for 3 tries, if pain is not relieved, go to hospital. Do
not exceed 3 tabs.
18. HTN normal range 90/60-120/80
3 types: essential, secondary, malignant
19. nonpharmalogi- low fat/salt diet, smoking cessation, exercise, relaxation and stress management
cal measures for
HTN
20. pharmacological alpha-adrengic blockers, beta blockers, alpha beta blockers, alpha2 adrenergic
measures for agonist, ACE inhibitors, angiotensin ll blockers, calcium channel blockers
HTN
2/8